Delivery Order SPE2DR25D1104-SPE2DR26FK487
- Not listed
- The Defense Logistics Agency awarded a $1,461 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 30 mg/30 mL vials on November 17, 2025, with completion scheduled for November 18, 2025. The contract was awarded on a non-competitive, firm fixed-price basis and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $6,238.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 1 mg/ml ampules with a ceiling value of $1,545.95. This firm fixed-price delivery order, which has an ultimate completion date of August 15, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 30 mg/30 mL vials with a ceiling value of $4,129.48. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $5,707.80. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was awarded on a competitive basis with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with a contract ceiling value of $9,695.03 and a firm fixed price structure. The order is non-competitive and scheduled for completion by December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a $4,176.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 0.15 mg epinephrine auto-injectors (two-pack units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,222.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 mg/mL vials, with a completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of epinephrine injection. This firm fixed-price delivery order, valued at $7,764.88, represents a non-competitive set-aside contract and is scheduled for completion by September 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK487Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Epinephrine 30 mg/30 mL vials at a firm fixed price of $3,179.45, with completion scheduled for November 25, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this prime indefinite delivery contract to supply a broad portfolio of pharmaceutical products and medical supplies to military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's contract history with the DLA demonstrates its capability to fulfill diverse medical procurement requirements, from specialty medications and generic drugs to vaccines and medical devices across multiple therapeutic domains, all through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/23/25 |